Nantes, France, April 15, 2026 – 7:30am CEST - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), a clinical-stage biotech company ...

When our body fights an infection, the immune system must quickly activate defenses and trigger a beneficial inflammatory response. It’s just as important to be able to resolve that inflammation and ...

The medical community increasingly recognizes chronic inflammation as a fundamental driver behind numerous health conditions, from obvious manifestations like rheumatoid arthritis and inflammatory ...

Researchers at Brigham and Women’s Hospital have identified a new class of small molecules that selectively shut down ...

In IAV-infected wild-type AECII, ELOVL5 promoted inflammation resolution and cell proliferation through both regulating lipid metabolism (promoting PUFAs generation while decreasing eicosanoid levels) ...

Myelodysplastic syndromes (MDS) are malignant disorders arising from hematopoietic stem cells, yet the precise epigenetic abnormalities occurring in the primitive stem cells remain poorly understood.

Researchers at University College London (UCL) have uncovered a key mechanism that helps the body switch off inflammation—a breakthrough that could lead to new treatments for chronic diseases ...

New research is shedding light on surprising ways to reduce chronic inflammation—including suggestions as simple as flossing your teeth. From infrared saunas to meditation, there are several steps you ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis (PsA), but their relative effects on pain, versus inflammation, are less ...